Workflow
Expedia: At 10x Price To Free Cash Flow, I'm Not Afraid Of AI (NASDAQ:EXPE)
Seeking Alpha· 2026-03-03 02:28
Since the start of the year, Expedia ( EXPE ) and Booking ( BKNG ), the two biggest companies in the online travel agency (OTA) sector, have seen their stock price decline by close to 25%. AI fears areAnalyst’s Disclosure: I/we have a beneficial long position in the shares of EXPE either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship ...
Expedia: At 10x Price To Free Cash Flow, I'm Not Afraid Of AI
Seeking Alpha· 2026-03-03 02:28
Core Insights - The stock prices of Expedia (EXPE) and Booking (BKNG), the two largest companies in the online travel agency (OTA) sector, have declined by nearly 25% since the beginning of the year due to fears surrounding artificial intelligence [1] Company and Industry Summary - Expedia and Booking are facing significant stock price declines, indicating potential challenges in the OTA sector [1] - The decline in stock prices reflects broader market concerns, particularly related to the impact of AI on the travel industry [1]
12 Dirt Cheap Stocks to Buy Now
Insider Monkey· 2026-03-03 02:24
On February 23, Pierre Ouimet, head investment strategist at UBS Canada, joined BNN Bloomberg to discuss the markets and provide a spotlight on undervalued sectors. Ouimet discussed market resilience amidst political friction between the US Supreme Court and President Donald Trump. He stated that while a Supreme Court decision had been reached, the administration’s push for a 10% global tariff suggested that trade uncertainties remain.Despite this, he maintained a positive outlook and noted that political p ...
MongoDB's stock sinks after earnings, signaling more tough times for the software sector
MarketWatch· 2026-03-03 02:23
Group 1 - The planned transition involving the exits of two sales leaders is causing concern among investors [1]
ARDENT HEALTH URGENT DEADLINE: Bragar Eagel & Squire, P.C. Reminds Ardent Health, Inc. Stockholders to Contact the Firm Before March 9th Regarding Their Rights
Globenewswire· 2026-03-03 02:23
Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. for alleged misrepresentation of financial data and inadequate insurance coverage, impacting investors who acquired shares during the specified class period [6]. Group 1: Allegations - The lawsuit claims that Ardent Health reported inflated accounts receivable and delayed recognizing losses on uncollectable accounts during the class period from July 18, 2024, to November 12, 2025 [6]. - It is alleged that the company did not maintain sufficient professional malpractice liability insurance to cover potential claims arising from its operations [6]. Group 2: Financial Impact - On November 12, 2025, Ardent Health disclosed a $43 million decrease in third quarter 2025 revenue due to revised assessments of accounts receivable collectability, which followed a transition to a new revenue accounting system [6]. - Following this announcement, Ardent Health's stock price dropped by $4.75 per share, a decline of nearly 34%, from $14.05 per share to $9.30 per share on November 13, 2025 [6]. Group 3: Legal Process - Investors who purchased Ardent Health securities during the class period have until March 9, 2026, to apply to the Court to be appointed as lead plaintiff in the lawsuit [6].
FBRT Investors Have Opportunity to Lead Franklin BSP Realty Trust, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Businesswire· 2026-03-03 02:19
Core Viewpoint - FBRT investors have the opportunity to lead a securities fraud lawsuit against Franklin BSP Realty Trust, Inc. with the Schall Law Firm [1] Group 1 - The lawsuit is focused on allegations of securities fraud involving Franklin BSP Realty Trust, Inc. [1] - The Schall Law Firm is actively seeking investors who wish to participate in the lawsuit [1] - This legal action presents a potential avenue for investors to seek redress for alleged financial misconduct [1]
This Dividend Stock Just Raised Its Payout By 16%. Time to Buy Shares?
The Motley Fool· 2026-03-03 02:13
Core Viewpoint - American Express has raised its quarterly dividend by 16% to $0.95 per share, indicating its attractiveness as a dividend stock despite a 17% decline in share price year-to-date [1][2] Business Performance - American Express reported a 10% year-over-year increase in fourth-quarter revenue, net of interest expense, reaching $19.0 billion [4] - The company's earnings per share (EPS) rose 16% to $3.53, showcasing strong operating leverage [5] - For the full year 2025, revenue, net of interest expense, also increased by 10% to approximately $72 billion, with EPS rising 15% when adjusted for one-time items [6] Future Outlook - Management's guidance for 2026 EPS is between $17.30 and $17.90, suggesting a year-over-year growth of about 14.4% at the midpoint, which supports the new annualized payout of $3.80 per share [7] - The expected dividend payments result in a payout ratio of just 21.6% based on the midpoint of the 2026 earnings guidance, allowing room for future dividend increases [8] Capital Return Strategy - In 2025, American Express returned $7.6 billion to shareholders, comprising $2.3 billion in dividends and $5.3 billion in share repurchases, reducing its share count by 7% since 2022 [9] Valuation Considerations - American Express trades at a price-to-earnings multiple of about 20, which is slightly above its five-year average of 18, reflecting expectations for continued double-digit earnings growth [11][12] - The company's affluent customer base provides a structural advantage, potentially insulating it from economic downturns [14] Investment Appeal - The combination of a 16% dividend increase, low payout ratio, double-digit earnings growth, and an aggressive share-repurchase program makes American Express an attractive option for investors seeking a growing income stream [15]
Oil rises as expanding US-Israeli conflict with Iran elevates supply risks
Reuters· 2026-03-03 02:12
Core Viewpoint - Oil prices are rising due to the escalating U.S.-Israeli conflict with Iran, which raises concerns about supply disruptions from the Middle East [1][3]. Oil Price Movements - Brent crude futures increased to $78.83 per barrel, up $1.10 or 1.4%, with a previous high of $82.37, marking a 6.7% increase [2]. - U.S. West Texas Intermediate crude rose by 74 cents or 1% to $71.97 per barrel, with a previous session high since June 2025, settling up 6.3% [3]. Geopolitical Context - The conflict has widened, with Israel conducting airstrikes in Lebanon and Iran targeting energy infrastructure in Gulf countries and tankers in the Strait of Hormuz [4]. - The Strait of Hormuz is critical, with about 20% of global oil demand transiting through it, alongside significant liquefied natural gas shipments [5]. Shipping and Insurance Concerns - Tankers are avoiding the Strait of Hormuz due to increased insurance cancellations, with Iranian officials claiming the waterway is closed to shipping [6]. - An incident involving a Honduran-flagged fuel tanker being attacked by drones highlights the risks in the region [7]. Market Predictions - Analysts expect elevated oil prices in the coming days, with Bernstein raising its 2026 Brent oil price forecast from $65 to $80 per barrel, and predicting potential prices of $120-$150 in a prolonged conflict scenario [7]. Refined Product Futures - Refined product futures are also rising, with Saudi Arabia shutting down its largest domestic oil refinery following a drone strike [8]. - U.S. ultra-low-sulfur diesel futures increased by 3.1% to $2.991, while gasoline futures rose by 1.1% after a previous climb of 3.7% [8].
FERMI DEADLINE FRIDAY: Bragar Eagel & Squire, P.C. Urgently Reminds Fermi, Inc. (NASDAQ:FRMI) Stockholders to Contact the Firm Before the Upcoming March 6th Class Action Deadline
Globenewswire· 2026-03-03 02:10
Core Viewpoint - A class action lawsuit has been filed against Fermi, Inc. for allegedly making materially false and misleading statements regarding its business operations and prospects, particularly concerning the Project Matador campus [4][8]. Allegation Details - The lawsuit claims that Fermi overstated tenant demand for the Project Matador campus [4] - It alleges that the company relied heavily on a single tenant's funding commitment for the project's financing [4] - There is a significant risk that this tenant may terminate its funding commitment [4] - As a result, the positive statements made by the defendants about the company's business were misleading and lacked a reasonable basis [4] Next Steps - Investors who purchased Fermi shares and suffered losses can contact the law firm for more information and to discuss their rights [5][8] - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is March 6, 2026 [8]